0001799828-20-000001.txt : 20200117 0001799828-20-000001.hdr.sgml : 20200117 20200117102038 ACCESSION NUMBER: 0001799828-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200117 DATE AS OF CHANGE: 20200117 EFFECTIVENESS DATE: 20200117 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EvolveImmune Therapeutics Holding Company, LLC CENTRAL INDEX KEY: 0001799828 IRS NUMBER: 843114936 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-358352 FILM NUMBER: 20532533 BUSINESS ADDRESS: STREET 1: C/O CANAAN PARTNERS STREET 2: 285 RIVERSIDE AVENUE, SUITE 250 CITY: WESTPORT STATE: CT ZIP: 06880 BUSINESS PHONE: 203-858-7389 MAIL ADDRESS: STREET 1: C/O CANAAN PARTNERS STREET 2: 285 RIVERSIDE AVENUE, SUITE 250 CITY: WESTPORT STATE: CT ZIP: 06880 D 1 primary_doc.xml X0708 D LIVE 0001799828 EvolveImmune Therapeutics Holding Company, LLC C/O CANAAN PARTNERS 285 RIVERSIDE AVENUE, SUITE 250 WESTPORT CT CONNECTICUT 06880 203-858-7389 DELAWARE None None Limited Liability Company true 2019 Stephen Bloch c/o Canaan Partners 285 Riverside Avenue, Suite 250 Westport CT CONNECTICUT 06880 Executive Officer President and a Manager Denis Patrick 9 Harvest Road New City NY NEW YORK 10956 Director Manager Hugo Beekman 800 Boylston Street Suite 2510 Boston MA MASSACHUSETTS 02199 Director Manager Alessandra Di Bacco c/o Takeda Ventures 300 Massachusetts Avenue Cambridge MA MASSACHUSETTS 02139 Director Manager Biotechnology Decline to Disclose 06b false 2020-01-08 false true false 0 35099985 17549992 17549993 false 8 0 0 0 No amounts other than ordinary course employment compensation is being paid to officers and managers. false EvolveImmune Therapeutics Holding Company, LLC Stephen Bloch Stephen Bloch President 2020-01-13